elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38979882-9B06E6A5-DA72-4B8C-BF0A-46185CA1F2AC
Q38979882-9B06E6A5-DA72-4B8C-BF0A-46185CA1F2AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-9B06E6A5-DA72-4B8C-BF0A-46185CA1F2AC
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
P2860
Q38979882-9B06E6A5-DA72-4B8C-BF0A-46185CA1F2AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-9B06E6A5-DA72-4B8C-BF0A-46185CA1F2AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2763e4c0e26e27b3af790892a90a869f6ed45005
P2860
Phase I study of the safety, pharmacokinetics and antitumor activity of famitinib.